Prokidney (PROK) Assets (2021 - 2026)
Prokidney's (PROK) quarterly Assets came in at $249.0 million in Q2 2026, down 33.08% year-over-year from $372.1 million in Q2 2025, and down 14.95% quarter-over-quarter from $292.8 million in Q1 2026.
Analysis
Prokidney (PROK) Assets (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Assets for 6 consecutive years, with $249.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets fell 33.08% year-over-year to $249.0 million in Q2 2026; TTM through Jun 2026 was $249.0 million, a 33.08% decrease from a year earlier, with the FY2025 full-year figure at $335.6 million, down 23.92% from the prior year.
- Assets was $249.0 million for Q2 2026 at Prokidney, down from $292.8 million in the prior quarter.
- Over five years, Assets peaked at $532.4 million in Q3 2022 and troughed at $249.0 million in Q2 2026.
- A 5-year average of $400.8 million and a median of $413.3 million in 2023 frame the typical range for Assets.
- Across the five-year window, Assets surged 40202.15% in 2022 and tumbled 33.08% in 2026, its largest moves.
- Over 5 years, Assets stood at $518.0 million in 2022, then retreated by 18.81% to $420.6 million in 2023, then gained by 4.88% to $441.1 million in 2024, then retreated by 23.92% to $335.6 million in 2025, then decreased by 25.79% to $249.0 million in 2026.
- The last three Assets figures came in at $249.0 million (Q2 2026), $292.8 million (Q1 2026), and $335.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.50 Bn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.65 Bn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 915.53 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 1.75 Bn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 985.10 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 1.39 Bn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 170.30 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 3.19 Bn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 502.87 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | 249.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 249.02 Mn |
| Mar 31, 2026 | 292.78 Mn |
| Dec 31, 2025 | 335.57 Mn |
| Sep 30, 2025 | 351.61 Mn |
| Jun 30, 2025 | 372.13 Mn |
| Mar 31, 2025 | 406.06 Mn |
| Dec 31, 2024 | 441.07 Mn |
| Sep 30, 2024 | 474.79 Mn |
| Jun 30, 2024 | 499.16 Mn |
| Mar 31, 2024 | 387.76 Mn |
| Dec 31, 2023 | 420.55 Mn |
| Sep 30, 2023 | 451.81 Mn |
| Jun 30, 2023 | 484.22 Mn |
| Mar 31, 2023 | 495.15 Mn |
| Dec 31, 2022 | 518.00 Mn |
| Sep 30, 2022 | 532.44 Mn |
| Jun 30, 2022 | 251.00 Mn |
| Mar 31, 2022 | 250.75 Mn |
| Dec 31, 2021 | 40.30 Mn |
| Sep 30, 2021 | 251.44 Mn |